The Europe nasal spray market is expected to project a CAGR of 9.27% during the forecast period, 2021-2028. Chronic rhinosinusitis (CRS) and nasal polyps are prevalent in Europe. In addition, respiratory allergies, pulmonary hypertension, occupational lung diseases, and chronic obstructive pulmonary disease (COPD) are the most common respiratory diseases in the region. Also, the aging population adds to the burden of respiratory disease in Europe.

EUROPE NASAL SPRAY MARKET FORECAST 2021-2028

Europe Nasal Spray Market by Product (Decongestion Nasal Spray, Steroid Nasal Spray, Saltwater Solution/saline Nasal Spray) Market by Prescription (Over the Counter, Prescribed) Market by Therapeutic (Antihistamine, Nasal Steroids, Anticholinergic, Mast Cell Inhibitor) Market by Application (Nasal Congestion, Allergic and Non-allergic Rhinitis, Vaccination, CNS Disorders, Other Applications) Market by End-user (Home Care Setting, ASC/clinics, Pharmacy, Hospital, Other End-users) by Geography.

Request free sample

The Europe nasal spray market is expected to project a CAGR of 9.27% during the forecast period, 2021-2028. Chronic rhinosinusitis (CRS) and nasal polyps are prevalent in Europe. In addition, respiratory allergies, pulmonary hypertension, occupational lung diseases, and chronic obstructive pulmonary disease (COPD) are the most common respiratory diseases in the region. Also, the aging population adds to the burden of respiratory disease in Europe.europe-nasal-spray-market

To know more about this report, request a free sample copy.

The Europe nasal spray market growth analysis includes the assessment of Italy, the United Kingdom, France, Germany, Poland, Russia, Belgium, and Rest of Europe. In Germany, 10-15% of adults are affected by chronic bronchitis, while 5-7% of adults and 10-15% of children have bronchial asthma, as per the Robert Koch Institute study. Also, allergies are increasingly prevalent among 18 to 79-year-olds. Moreover, contact allergies, atopic dermatitis, asthma, and hay fever are the common allergic diseases in the country. Further, bronchiectasis is common among the aging population of Germany, which accounts for 22% of the total population.

In Italy, chronic rhinosinusitis is a common disease. Also, as per the industry sources, almost 19.8% of the population has allergic rhinitis (AR). Chronic Respiratory Diseases (CRDs) are common in the adult population. There has been an increase in air pollution in the country in the last few years. Particle pollution is responsible for heart and breathing problems, causing 9% of deaths of people aged above 30. Moreover, with the growing elderly population, there is an increasing risk of respiratory diseases. Such factors contribute to the market growth of these countries.

Allergan Plc develops and markets branded pharmaceutical products, regenerative medicine, and surgical products. It offers products in several therapeutic areas, including medical aesthetics & dermatology, urology, eye care, central nervous system, etc. The company has a business presence in Europe, the US, Asia-Pacific, etc., with headquarters in Dublin, Ireland.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • RISING ADOPTION OF NASAL SPRAYS AMONG PATIENTS
        • GROWING ACCEPTANCE OF SELF-MEDICATION
        • INCREASING INTRANASAL VACCINES FOR COVID-19
      • KEY RESTRAINTS
        • OVERUSE RISKS ASSOCIATED WITH NASAL SPRAYS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON NASAL SPRAY MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY PRODUCT
      • DECONGESTION NASAL SPRAY
      • STEROID NASAL SPRAY
      • SALTWATER SOLUTION/SALINE NASAL SPRAY
    3. MARKET BY PRESCRIPTION
      • OVER THE COUNTER
      • PRESCRIBED
    4. MARKET BY THERAPEUTIC
      • ANTIHISTAMINE
      • NASAL STEROIDS
      • ANTICHOLINERGIC
      • MAST CELL INHIBITOR
    5. MARKET BY APPLICATION
      • NASAL CONGESTION
      • ALLERGIC AND NON-ALLERGIC RHINITIS
      • VACCINATION
      • CNS DISORDERS
      • OTHER APPLICATIONS
    6. MARKET BY END-USER
      • HOME CARE SETTING
      • ASC/CLINICS
      • PHARMACY
      • HOSPITAL
      • OTHER END-USERS
    7. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY DRIVERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PARTNERSHIPS & AGREEMENTS
      • COMPANY PROFILES
        • AKORN INCORPORATED
        • ALLERGAN PLC
        • APOTEX INC
        • BHARAT BIOTECH
        • CATALENT INC
        • CIPLA LIMITED
        • GLAXOSMITHKLINE PLC
        • JOHNSON & JOHNSON
        • NOVARTIS INTERNATIONAL AG
        • PFIZER INC
        • PROCTOR & GAMBLE CO (P&G)
        • SANOTIZE RESEARCH AND DEVELOPMENT
        • SUN PHARMACEUTICALS INDUSTRIES LTD
        • TEVA PHARMACEUTICALS INDUSTRIES LTD
        • VIATRIS

    TABLE LIST

    TABLE 1: MARKET SNAPSHOT – NASAL SPRAY

    TABLE 2: EUROPE NASAL SPRAY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: EUROPE NASAL SPRAY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: EUROPE NASAL SPRAY MARKET, BY PRESCRIPTION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: EUROPE NASAL SPRAY MARKET, BY PRESCRIPTION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: EUROPE NASAL SPRAY MARKET, BY THERAPEUTIC, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: EUROPE NASAL SPRAY MARKET, BY THERAPEUTIC, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: EUROPE NASAL SPRAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: EUROPE NASAL SPRAY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: EUROPE NASAL SPRAY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: EUROPE NASAL SPRAY MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: EUROPE NASAL SPRAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: EUROPE NASAL SPRAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: KEY PLAYERS IN EUROPE NASAL SPRAY MARKET

    TABLE 15: LIST OF MERGERS & ACQUISITIONS

    TABLE 16: LIST OF PARTNERSHIPS & AGREEMENTS

     

    FIGURE LIST 

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: EUROPE NASAL SPRAY MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2020

    FIGURE 6: EUROPE NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2028 (IN $ MILLION)

    FIGURE 7: EUROPE NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2028 (IN $ MILLION)

    FIGURE 8: EUROPE NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY, 2021-2028 (IN $ MILLION)

    FIGURE 9: EUROPE NASAL SPRAY MARKET, GROWTH POTENTIAL, BY PRESCRIPTION, IN 2020

    FIGURE 10: EUROPE NASAL SPRAY MARKET, BY OVER THE COUNTER, 2021-2028 (IN $ MILLION)

    FIGURE 11: EUROPE NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2028 (IN $ MILLION)

    FIGURE 12: EUROPE NASAL SPRAY MARKET, GROWTH POTENTIAL, BY THERAPEUTIC, IN 2020

    FIGURE 13: EUROPE NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2028 (IN $ MILLION)

    FIGURE 14: EUROPE NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2028 (IN $ MILLION)

    FIGURE 15: EUROPE NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2028 (IN $ MILLION)

    FIGURE 16: EUROPE NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2028 (IN $ MILLION)

    FIGURE 17: EUROPE NASAL SPRAY MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020

    FIGURE 18: EUROPE NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2028 (IN $ MILLION)

    FIGURE 19: EUROPE NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS, 2021-2028 (IN $ MILLION)

    FIGURE 20: EUROPE NASAL SPRAY MARKET, BY VACCINATION, 2021-2028 (IN $ MILLION)

    FIGURE 21: EUROPE NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2028 (IN $ MILLION)

    FIGURE 22: EUROPE NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 23: EUROPE NASAL SPRAY MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

    FIGURE 24: EUROPE NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2028 (IN $ MILLION)

    FIGURE 25: EUROPE NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2028 (IN $ MILLION)

    FIGURE 26: EUROPE NASAL SPRAY MARKET, BY PHARMACY, 2021-2028 (IN $ MILLION)

    FIGURE 27: EUROPE NASAL SPRAY MARKET, BY HOSPITAL, 2021-2028 (IN $ MILLION)

    FIGURE 28: EUROPE NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

    FIGURE 29: EUROPE NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 30: UNITED KINGDOM NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 31: GERMANY NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 32: FRANCE NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 33: ITALY NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 34: RUSSIA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 35: BELGIUM NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 36: POLAND NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 37: REST OF EUROPE NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

     

    1. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY DRIVERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. MARKET BY PRODUCT
      • DECONGESTION NASAL SPRAY
      • STEROID NASAL SPRAY
      • SALTWATER SOLUTION/SALINE NASAL SPRAY
    2. MARKET BY PRESCRIPTION
      • OVER THE COUNTER
      • PRESCRIBED
    3. MARKET BY THERAPEUTIC
      • ANTIHISTAMINE
      • NASAL STEROIDS
      • ANTICHOLINERGIC
      • MAST CELL INHIBITOR
    4. MARKET BY APPLICATION
      • NASAL CONGESTION
      • ALLERGIC AND NON-ALLERGIC RHINITIS
      • VACCINATION
      • CNS DISORDERS
      • OTHER APPLICATIONS
    5. MARKET BY END-USER
      • HOME CARE SETTING
      • ASC/CLINICS
      • PHARMACY
      • HOSPITAL
      • OTHER END-USERS

     

     

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type